Granata Bio

Duxbury, MA · Founded 2018 · Privately Held (backing)

Operator of a biopharma company intended to find and grow fertility programs for patients. Granata Bio is based in Duxbury, MA and was founded in 2018. It was valued at $129 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $31.1 million across 2 recorded rounds; the latest was a $13.8 million early-stage round in Dec 2024.

PMV mark · valuation
$129.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$31.1M
Last round
Early Stage VC
Dec 2024
How much has Granata Bio raised?
$31.1Macross 2 recorded rounds · Oct 2023 – Dec 2024

Most recently, Granata Bio raised $13.8M in its Early Stage VC (Dec 2024).

Free account
More of Granata Bio with a free account
  • ·Watch Granata Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Granata Bio round by round

2 rounds
Dec 2024Early Stage VC$13.8MSEC filing▮
3 investors participated
Oct 2023Early Stage VC$10.1MSEC filing▮
10 investors participated

How much has Granata Bio raised?

Granata Bio has raised $31.1 million in total; 2 of its rounds are on record. The largest on record was a $13.8 million early-stage round in Dec 2024.

Granata Bio has filed 2 Form Ds with the SEC since 2023, most recently in Dec 2024 ($13.8 million sold to 3 investors).

Granata Bio investors

9 investors are on record for Granata Bio, including Alumni Ventures, Mana Ventures, Gaingels and GV. By type, the record holds 6 venture capital firms. The early-stage round in Dec 2024 drew 3 investors.

For fundraisers
Raising for a company like Granata Bio?

9 investors have backed Granata Bio.

See all 9 investors →

Frequently asked about Granata Bio

How much has Granata Bio raised?
Granata Bio has raised $31.1M in total across 2 recorded funding rounds.
When was Granata Bio's last funding round?
Granata Bio's most recent recorded round was Early Stage VC in Dec 2024, raising $13.8M.